Scinai Immunotherapeutics Ltd. (SCNI) Net Income by Year
Scinai Immunotherapeutics Ltd. reported a net loss of $8.3M in fiscal year 2025. This represents a decrease of 273.2% from the prior fiscal year. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters Scinai Immunotherapeutics Ltd. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
SCNI Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
SCNI Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Scinai Immunotherapeutics Ltd. financials
Frequently Asked Questions
What was Scinai Immunotherapeutics Ltd.'s net income in fiscal year 2025?
Scinai Immunotherapeutics Ltd. reported a net loss of $8.3M in fiscal year 2025.
How fast is Scinai Immunotherapeutics Ltd.'s net income growing?
Scinai Immunotherapeutics Ltd. (SCNI) net income fell by 273.2% year over year, from $4.8M to -$8.3M in fiscal year 2025.
How has Scinai Immunotherapeutics Ltd.'s net income changed over the years?
Across the 5 fiscal years this page covers, Scinai Immunotherapeutics Ltd. (SCNI) net income went from -$8.2M in fiscal year 2021 to -$8.3M in fiscal year 2025.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Scinai Immunotherapeutics Ltd. (SCNI) reported on that line in every period on record.